HPC
MRNA icon

HM Payson & Co’s Moderna MRNA Stock Holding History

HM Payson & Co’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.5K Hold
50
– – ﹤0.01% 1010
2026
Q1 		$2.54K Hold
50
– – ﹤0.01% 1020
2025
Q4 		$1.48K Hold
50
– – ﹤0.01% 1083
2025
Q3 		$1.29K Hold
50
– – ﹤0.01% 1036
2025
Q2 		$1.38K Hold
50
– – ﹤0.01% 951
2025
Q1 		$1.42K Hold
50
– – ﹤0.01% 984
2024
Q4 		$2.08K Sell
50
-106
-68% -$5.07K ﹤0.01% 958
2024
Q3 		$10.4K Buy
156
+5
+3% +$459 ﹤0.01% 832
2024
Q2 		$17.9K Buy
151
+10
+7% +$1.26K ﹤0.01% 778
2024
Q1 		$15K Hold
141
– – ﹤0.01% 779
2023
Q4 		$14K Sell
141
-244
-63% -$20.5K ﹤0.01% 785
2023
Q3 		$39.8K Buy
385
+2
+0.5% +$223 ﹤0.01% 623
2023
Q2 		$46.5K Buy
383
+1
+0.3% +$133 ﹤0.01% 587
2023
Q1 		$58.6K Buy
382
+10
+3% +$1.65K ﹤0.01% 545
2022
Q4 		$66.8K Sell
372
-290
-44% -$47.4K ﹤0.01% 522
2022
Q3 		$78K Buy
662
+300
+83% +$45.5K ﹤0.01% 507
2022
Q2 		$52K Buy
362
+55
+18% +$7.86K ﹤0.01% 571
2022
Q1 		$53K Buy
307
+6
+2% +$1.01K ﹤0.01% 591
2021
Q4 		$76K Buy
301
+156
+108% +$45.6K ﹤0.01% 540
2021
Q3 		$56K Buy
145
+2
+1% +$738 ﹤0.01% 574
2021
Q2 		$34K Buy
143
+3
+2% +$536 ﹤0.01% 657
2021
Q1 		$18K Hold
140
– – ﹤0.01% 780
2020
Q4 		$15K Buy
140
+100
+250% +$10.1K ﹤0.01% 824
2020
Q3 		$3K Hold
40
– – ﹤0.01% 927
2020
Q2 		$3K Buy
+40
New +$2.19K ﹤0.01% 822

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

HM Payson & Co's MRNA Position: Q2 2026 in Review

HM Payson & Co held its Moderna (MRNA) position steady in Q2 2026 at 50 shares worth $3.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1010.

HM Payson & Co first reported a position in MRNA in Q2 2020 and has held it in 25 quarters since. The position peaked at $78K in Q3 2022. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • HM Payson & Co held 50 shares of Moderna worth $3.5K as of Q2 2026.
  • HM Payson & Co left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of HM Payson & Co's portfolio in Q2 2026, its #1010 holding.
  • HM Payson & Co first reported a position in Moderna in Q2 2020 and has held it in 25 quarters since.
  • HM Payson & Co's Moderna position peaked at $78K in Q3 2022.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.